Search results
If you are looking for research summaries please go to the research summary page.
934 results for at
- Our plans and proposals
- Minutes of the meeting on 3 April 2019
- Research registration and research project identifiers
- A new strategy for research transparency. The HRA response to the Science and Technology Committee
- Through a glass darkly. A blog on research transparency from Professor Andrew George
- Technical Assurance review fee
- Research waste and ensuring transparency, a blog by Juliet Tizzard
- Tribute to Professor Janet Marsden
- HRA project hopes to help student researchers get it right first time
- Blog: GDPR guidance updated as new law approaches
- GDPR technical guidance: transparency
- Template email for sponsors sharing a GDPR amendment
- The NHS R&D Forum 2018The Annual NHS R&D Forum is taking place on 13, 14 and 15 May at Celtic Manor, Newport, Wales.
- New framework for UK health and social care research launchedTransparency, public involvement, safety and proportionality must be at the centre of UK health research, a new position statement published today has demanded.
- Examples of substantial and non-substantial amendmentsFind examples of substantial and non-substantial amendments.
- Publication and dissemination of research findingsWe publish details of all research reviewed by the Research Ethics Committees (RECs) in the UK as a research summary record. This record consists of some basic information about the research (e.g. title, available registry reference numbers), summary of the research as submitted to the REC and the REC’s opinion.
- HRA Approval in action: First patient and first site recruited in a global studyBiotechnology company Amgen was keen to get HRA Approval for an international research study into the effectiveness of a new treatment for patients with aggressive B-cell Non-Hodgkin’s lymphoma.
- New National Research and Ethics Advisors’ Panel starts workThe range of independent advice and expertise available to the Health Research Authority has been broadened with the expansion in March of the HRA’s national panel of experts.
- Research in emergency settingsEmergency research poses its own set of challenges in terms of providing information about the research and obtaining consent.
- Regenerative medicineFor the purposes of the content provided within this area we have adopted the definition of the term “regenerative medicine” that was used in the House of Lords Regenerative Medicine Report. "Regenerative medicine is used to refer to methods to replace or regenerate human cells, tissues or organs in order to restore or establish normal function. This includes cell therapies, tissue engineering, gene therapy and biomedical engineering techniques, as well as more traditional treatments involving pharmaceuticals, biologics and devices."